Diferencia entre revisiones de «Methotrexate»
(Switch SMW query from broadtable to table format for better layout with TOC) |
|||
| (No se muestran 2 ediciones intermedias de 2 usuarios) | |||
| Línea 3: | Línea 3: | ||
*Dosage Forms: | *Dosage Forms: | ||
*Routes of Administration: IV/IM, oral | *Routes of Administration: IV/IM, oral | ||
*Common Trade Names: | *Common Trade Names: Trexall, Rheumatrex, Otrexup | ||
==Adult Dosing== | ==Adult Dosing== | ||
| Línea 52: | Línea 52: | ||
*Inhibits dihydrofolate reductase→ blocks DNA synthesis and thus, cellular replication/repair | *Inhibits dihydrofolate reductase→ blocks DNA synthesis and thus, cellular replication/repair | ||
==Comments== | ==Comments== | ||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Methotrexate]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
Revisión actual - 21:57 20 mar 2026
Administration
- Type: Immunosuppressant/antineoplastic
- Dosage Forms:
- Routes of Administration: IV/IM, oral
- Common Trade Names: Trexall, Rheumatrex, Otrexup
Adult Dosing
Ectopic pregnancy
- Single-dose regimen: Methotrexate 50 mg/m2
Pediatric Dosing
Special Populations
- Pregnancy Rating: X
- Lactation risk: Infant risk has been determined (risk of serious adverse effects for infant)
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
- Breastfeeding, pregnant, or possibility of impregnating someone
- Blood dyscrasias
- Chronic liver disease
Adverse Reactions
Serious
- Hepatotoxicity
- Nephrotoxicity
- Myelosuppression, aplastic anemia, pancytopenia
- Infectious disease
- Tumor lysis syndrome
- GI bleed
- Neurotoxicity, seizure
- Pericardial effusion
- TEN
Common
- Nausea/vomiting, diarrhea
- Stomatitis
- Leukopenia, thrombocytopenia
- Alopecia, photosensitivity, rash
- Dizziness
Pharmacology
- Half-life: 8-15hr
- Metabolism: Extensive hepatic and intracellular
- Excretion: Mostly renal. Dialyzable.
Mechanism of Action
- Inhibits dihydrofolate reductase→ blocks DNA synthesis and thus, cellular replication/repair
Comments
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.
| Indication | Dose | Context | Route | Population |
|---|---|---|---|---|
| Ectopic pregnancy | 50 mg/m2 IM | Medical management (single dose regimen) | IM | Adult |